Monday - November 16, 2026
Ashurst Perkins Coie advises Pacira BioSciences, Inc. on its $1.65 billion acquisition by Viatris Inc.
October 08, 2026
SEATTLE, Washington, Oct. 8 [Category: BizLaw/Legal] -- Ashurst Perkins Coie, a law firm, posted the following news:

* * *

Ashurst Perkins Coie advises Pacira BioSciences, Inc. on its $1.65 billion acquisition by Viatris Inc.

*

DENVER (October 8, 2026)--Ashurst Perkins Coie is pleased to have advised Pacira BioSciences, Inc. (Nasdaq: PCRX), a leader in innovative non-opioid pain therapies, on its $1.65 billion acquisition by Viatris Inc. (Nasda . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products